The bioXclusters project partners are planning a trade mission to Shanghai (China) to learn mor about the life sciences sector in this country. The mission will take place from the 26th to the 31st May 2013 and plans to attend two events. All partners in the project as well as some companies located in the bioXcluster regions will take part in this mission. Continue reading
See this video about Mr. Gao Rohghui’s recent visit to Europe. It gives a great overview of what to do and what not to do when entering the Chinese life sciences market.
Until recently, the history of the pharmaceutical industry in China was more about imitation than innovation.
According to a report by London-based market researcher Scrip Intelligence, approximately 40% of biotech sales in China come from biosimilars. This would explain why the market for biologics in China has been growing at a rate of more than 25% a year, while total sales of biotech drugs are still only $1.5 billion a year. Read more
Gao RongHui has recently visited the bioXclusters regions where he has had the opportunity to learn about its different organisations and present the Chinese market to cluster company members in workshops.
Gao RongHui is a senior consultant specialised in life sciences, based in Shanghai. During his trip to Europe, he visited the four bioXclusters’ regions: Bavaria, Catalonia, Piedmont and Rhône-Alpes where he spoke about the opportunities of the biotech, biomedical and medtech sectors in China.
This report is a compilation of information about the Chinese life sciences market. It pools information from a variety of different sources and contains practical tips, an overview of the sector and details opportunities that exist in this country. Open the report in the Docs&Resources section